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Enantioselective Oxidative Rearrangements with Chiral
Hypervalent Iodine Reagents
Michael Brown,[a] Ravi Kumar,[a] Julia Rehbein,[b] and Thomas Wirth*[a]
Abstract: A stereoselective hypervalent iodine-promoted
oxidative rearrangement of 1,1-disubstituted alkenes has
been developed. This practically simple protocol provides
access to enantioenriched a-arylated ketones without the
use of transition metals from readily accessible alkenes.
Introduction
Rearrangements induced by iodine(III) reagents are very versa-
tile protocols to induce complexity and new stereocentres into
molecules. Hypervalent iodine reagents exhibit attractive fea-
tures of low cost, low toxicity and are environmentally
benign.[1] Their highly electrophilic nature[2] coupled with the
ability of the aryliodine(III) moiety to act as an excellent leaving
group have seen their employment as much safer alternatives
to more toxic heavy metal-based oxidants, such as lead(IV) ace-
tate, mercury(II) and thallium(III) salts. However, it remains
a challenge to develop techniques to rival the synthetic utility
of first- and second-row transition-metal catalysts. Great effort
has been invested in the development of efficient methods for
the synthesis of a-aryl carbonyl compounds, in part due to
their importance to the pharmaceutical industry.[3] Driven
primarily by the groups of Buchwald,[4] Hartwig,[5] Miura[6] and
Fu,[7] palladium(0)[8] and nickel(0)[9]-catalyzed intermolecular ar-
ylation and cross-coupling methods have emerged as powerful
synthetic tools (Scheme 1a).[10] Increasing emphasis has
recently been placed on the use of copper(I) catalysis,[11] gold
catalysis[12] and more sustainable routes to a-arylated ketones,
such as metal-free intermolecular reactions[13] and rearrange-
ments.[14]
Results and Discussion
Hypervalent iodine reagents are known for their ability to
promote efficient oxidation reactions of unsaturated systems.
Following the seminal report by Koser et al. describing the
oxidative rearrangement of 1,1-diphenylethene with hydroxy-
(tosyloxy)iodobenzene (1; Figure 1),[15] hypervalent iodine
reagents have been utilised to generate cationic intermediates
leading to oxidative skeletal rearrangements.[16] Ring-contrac-
Scheme 1. Asymmetric strategies to a-arylated ketones.
Figure 1. Hypervalent iodine reagents.
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tion and ring-expansion reactions of cyclic alkenes have been
demonstrated using 1,[17] and 1,2-aryl shifts of acrylamide de-
rivatives,[18] arylalkenes[19] and 1,1-diphenylalkenes[20] have been
performed in a racemic fashion using 1 or its derivatives. Al-
though chiral hypervalent iodine reagents in stereoselective re-
actions have received much attention,[21] their use in stereose-
lective rearrangements are still scarce. We recently reported
the first highly stereoselective rearrangement of chalcones to
a-aryl acetals promoted by hypervalent iodine reagent 2a[22] in
the presence of trimethylsilyltriflate (TMSOTf; Scheme 1b).[23]
As part of our studies on asymmetric a-arylation strategies,
herein, we report the transformation of aryl alkenes to a-aryl
ketones (Scheme 1c). This transformation can also be per-
formed using other reagents,[24] but the important progress de-
scribed herein is the first use of chiral iodine(III) derivatives
under base-free conditions to achieve the enantioselective
synthesis of tertiary stereocenters of enolizable products.
We initially investigated the reaction of 1,1-diphenylpentene
4a with reagent 2b[25] in dichloromethane/2,2,2-trifluoroetha-
nol (TFE; 10:1) in the presence of methanol as a nucleophilic
oxygen source. No reaction occurred in the absence of any ac-
tivating agent. When p-toluenesulfonic acid monohydrate was
added to 2b before addition of the alkene, ketone 7a result-
ing from an 1,2-aryl migration and concomitant oxidation was
obtained with good stereoselectivity albeit in moderate yield
(Table 1, entry 2).
Addition of p-toluenesulfonic acid monohydrate to a mixture
of diacetate 2b and alkene at ¢78 8C to generate reagent 2c
in situ gave superior results (Table 1, entry 3). The postulated
enantiopure hydroxy(tosyloxy) derivative 2c could not be satis-
factorily characterized by NMR spectroscopy due to its instabil-
ity, but its formation was evidenced by a shift in UV/Vis spec-
trum absorption maxima in the reaction solvent system (see
the Supporting Information). In the absence of methanol, the
reaction proceeded satisfactorily, but required nine hours for
completion (Table 1, entries 4 and 11). Limiting the amount of
methanol to three equivalents minimized methoxy addition
across the double bond and further improved the yield. Under
these conditions, iodoarene 2b gave the highest enantioselec-
tivity (Table 1, entry 7). Triflic acid (TfOH) and trimethylsilyl-
triflate (TMSOTf) also proved to be potent activators for 2b,
although addition of six equivalents of methanol was required
for these reactions to reach completion. It is assumed that
rapid methanolysis of TMSOTf generates triflic acid in situ as
the activating agent. Attempts to further improve the enantio-
selectivity of this transformation employing chiral activators,
such as (1R)-(¢)- and (1S)-(+)-10-camphorsulfonic acid, did not
improve the outcome (Table 1, entries 12 and 13). Reaction of
6a with other chiral iodanes 4 and 5 gave the desired ketone
with reduced enantioselectivities. Reagent 4[26] led to the for-
mation of (S)-7a with 16% enantiomeric excess, whereas 44%
ee could be achieved by using iodane 5[27] (Table 1, entries 14
and 15). In each reaction, the reduced iodoarene could be
recovered (85–90%) and was re-oxidized without loss of
enantiomeric purity.
Under the optimized reaction conditions, a range of 1,1-
diphenyl alkenes (6b–i) gave the corresponding a-phenyl
ketones (7b–i) in good yields (Scheme 2).[28] The absolute
Table 1. Optimization of rearrangement conditions.






1 2b – 6 n.r.[b] –
2 2b TsOH·H2O 6 49
[c] 81
3 2b TsOH·H2O 6 78 92
4 2b TsOH·H2O – 81
[d] 92
5 2b TfOH 6 84 90
6 2b TMSOTf 6 86 90
7 2b TsOH·H2O 3 87 94
8 2a TsOH·H2O 3 86
[e] 88
9 3 TsOH·H2O 3 80 83
10 2b[f] TsOH·H2O 3 85 92








14 4 TsOH·H2O 3 55
[h] 16
15 5 TsOH·H2O 3 77 44
[a] [Iodane]=0.09m. [b] Reaction conditions: RT, 6 h. [c] Hypervalent
iodine reagent prepared at 0 8C. [d] Reaction time 9 h. [e] Reaction time
5 h. [f] [Iodane]=0.2m. [g] H2O (3 equiv) ; reaction time 9 h. [h] Reaction
conditions: ¢78 to 0 8C, (S)-7a was obtained.
Scheme 2. Scope of the oxidative rearrangement. [a] Conditions: TMSOTf
(1.2 equiv), MeOH (6 equiv). [b] Obtained as the racemate. [c] Enantiomers
inseparable under the HPLC conditions employed. [d] Yield obtained on
reaction with (diacetoxyiodo)benzene as racemate.
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configuration of 7b, k and o was determined by comparison
of the optical rotation with known compounds (see the Sup-
porting Information). Using the identical enantiopure reagent
2b, the same direction of asymmetric induction is assumed in
the other products 7. Sterically hindered iso-propyl substituted
styrene 6c rearranged with only moderate enantioselectivity,
which was not improved by the use of a less sterically encum-
bered reagent 3,[29] which gave 7c in 88% yield, and only 39%
ee was obtained. It is noteworthy that access to ketone 7c is
not possible by the intermolecular catalytic Negishi coupling
protocol reported by Lou and Fu.[7c] 1,2-Substituted styrenes
6 j–r (used as a mixture of E and Z isomers) gave the expected
rearranged ketones in good yields. It should be noted that in
the case of 7k–p, products resulting from alkyl-group migra-
tion were not observed. In the reaction of 7 j, traces of an iso-
propyl migration product were observed in the 1H NMR spec-
trum of the crude mixture, but not in sufficient quantities to
allow characterization.
When alkene 6n containing cyclopentyl ring was subjected
to the rearrangement reaction conditions, rearranged ketone
7n was obtained in good yield and high selectivity (87% ee).
Unfortunately, 1-cyclopropyl-2-methylstyrene bearing a cyclo-
propyl ring as substituent, gave a complex reaction mixture.
Furthermore, oxidation of (E/Z)-1-(but-2-en-2-yl)naphthalene
(6p) with reagent 2b gave a mixture of 3-(naphthalene-1-yl)-
butan-2-one (7p ; 89% ee) and 3-(naphthalene-2-yl)butan-2-
one with 85% ee.
Heterocyclic substituted alkenes were also used in the oxida-
tive rearrangement. An E/Z mixture of the alkene 6q bearing
a thiophene moiety gave rearranged product 7q through
thienyl migration in good yields. Compound 6r gave the
phenyl migrated product 7r in 18% yield with 55% ee
together with various side products. Alkenes with pyridyl
substituent, (E)-2-(1-phenylprop-1-en-1-yl)pyridine and (Z)-2-(1-
phenylprop-1-en-1-yl)pyridine, afforded only trace amounts of
the rearranged products.
Stereoselective rearrangements were also attempted with
tetra-substituted alkenes to construct quaternary carbon
stereogenic centres. 1,1-Diphenyl-2-methylbut-1-ene (6s), pre-
pared by a one-pot cross-Pinacol coupling/rearrangement reac-
tion,[30] was also exposed to the rearrangement reaction. The
use of (diacetoxyiodo)benzene as iodine(III) reagent gave the
rearranged product in 12% isolated yield after nine hours;
however, the rearranged ketone by using reagent 2b was not
obtained in sufficient quantities to allow full characterization.
When excess of alkene 6m (E/Z : 1:2.5; 2 equiv) was subject-
ed to the standard reaction conditions, unreacted 6m was
recovered with an enriched E/Z ratio of 3:1, suggesting that
(Z)-aryl substituent migration is faster at ¢78 8C. In addition,
(E)-6t and (Z)-6t were independently synthesized and rear-
ranged efficiently to ketones 7t and t’, respectively, with high
stereoselectivities (Scheme 3). Under the standard reaction
conditions (¢78 8C), the (Z)-aryl substituent migrates selectively
with 2b ; however, when the reaction is conducted at higher
temperature (¢20 8C), (E)-aryl substituent migration became
competitive ((Z)-6t!7t’/t (8:1)), as was determined by 1H NMR
spectroscopy. A similar trend in chemoselectivity was obtained
with the Koser reagent. The reaction of (Z)-6t at ¢78 8C gave
a ratio of 7t’/t (5:1), which diminished to 7t’/t (1:1) when the
reaction was performed at room temperature.
Taking this evidence into account, a plausible mechanistic
pathway is proposed in Scheme 4. Electrophilic addition of
iodine 2c to the alkene followed by ring opening with metha-
nol would result in l3-iodane B. Following bond rotation to C,
reductive elimination of the aryliodonio moiety gave a 1,2-aryl
migration with stereochemical inversion at this centre to give
the observed product. However, it is not entirely clear why
only conformer C is reactive at lower temperature. It is likely
that relief of steric interactions between the Ar and R groups
in C contribute to an increased propensity for this conformer
to rearrange, providing the (Z)-aryl migration product.
Key intermediate in the proposed mechanism is the cyclic
iodonium ion A, because its restricted conformational space
allows a regio- and stereoselective nucleophilic attack, as was
demonstrated by using methanol (Scheme 4). At the same
time, it may serve as the starting point for the formation of
a non-classical carbenium ion that could lead also to the major
product observed (Scheme 5).
DFT calculations were employed to analyse the bonding sit-
uation and the stability of A1 in comparison to the “open”
Scheme 3. Chemoselectivity of the oxidative rearrangement. [a] Minor
enantiomer was not detected.
Scheme 4. Plausible reaction pathway to explain the observed regio- and
stereochemical outcome.
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form, (carbenium ion) and the nonclassical form A2. Although
iodonium ions are usually preferred over carbenium ions in the
addition of iodine electrophiles to alkenes,[31] the structures de-
scribed herein with at least a pronounced carbenium ion char-
acter in the benzylic position could be possible intermediates
(Figure 2). To elucidate the relative energy of the cyclic and
open cationic form, relaxed potential energy surface (PES)
scans were performed[32] by driving the C1¢I bond (0.025 æ
over 20 steps, two consecutive scans) starting from minimum
A1[33] (r(C1¢I) 2.90 æ, r(C2¢I) 2.70 æ). The circled points were
subjected to geometry optimization and frequency analysis ;
however, only A1 could be confirmed as a ground-state
structure (Figure 2).
As was expected, the energy rises with increasing r(C1¢I),
but with 9.6 kcalmol¢1 for a full acyclic carbenium ion (r(C1¢I)
3.40 æ, r(C2¢I) 2.73 æ), the anticipated barrier for the processes
of ring opening should be accessible at room temperature.
However, the associated structure could neither be character-
ized as a transition state nor as a ground state on the free
energy surface, leaving room for other mechanistic scenarios,
as indicated in Scheme 5. A second interesting feature of the
PES scan plot is the shallow minimum at r(C1¢I) 3.30 æ, r(C2¢I)
2.69 æ (Figure 2). Starting geometry optimizations at this local
minimum on the electronic energy surface did not lead to
a stable minimum geometry with more carbenium-ion charac-
ter on the PES. On the contrary, the optimized structures re-
laxed back to the structure A1. Also, extensive search and opti-
mizations under consideration of arene participation (A2) to
stabilize a more carbenium-ion-like intermediate did not result
in the identification of local minima (see the Supporting
Information). To exclude that overbinding inherent to the
M06-2X[34] functional due to the incorporation of dispersion
corrections is biasing the geometry search, B3LYP[35] was used
as a complementary method, because it has no dispersion cor-
rection. The obtained B3LYP-structures of A1-p, though looser
(+7% for r(C1¢I) and +1% for r(C2¢I) compared to the
M06-2X structure) and more asymmetric[36] in their C¢I bonds
(r(C1¢I) 3.10 æ, r(C2¢I) 2.73 æ) did not differ qualitatively.
Consequently, the proposed iodonium ion A1 is believed to be
the most prevalent structure in the reaction mechanism.
A number of commercially available symmetrical ketones
was used to prepare alkenes 6u–bb to determine the effect of
arene-substitution pattern on the enantioselectivity of the rear-
rangement, as shown in Table 2. ortho-Substitution as in 6aa
completely shuts down the migration pathway with 2b ; even
with PhI(OAc)2 and TMSOTf upon heating at reflux for six
hours, only a trace of the expected ketone was observed.
Moderately, electron-rich alkene 6y rearranges rapidly under
the reaction conditions. Highly electron-rich alkenes, such as
anisole derivative 6bb, are preferential oxidized at the alkene
C2 position, leading to 1,1-di(4-methoxyphenyl)pentan-2-one
(72% yield) as the major product (Table 2, entry 8).
The employment of catalytic amounts of iodine reagent in
combination with an external oxidant for hypervalent iodine-
mediated transformations is an active area of research.[37] It has
been shown that electron-rich 1-alkyl-1-arylethenes can
rearrange to ketones with sub-stoichiometric quantities of
4-methyl-iodobenzenesulfonic acid.[24b] We found that more
electron-rich 1,1-diarylalkenes, such as 6a, suffered from direct
reaction with the terminal oxidants in preference to the
Scheme 5. According to natural bond orbital (NBO) data of A1, the forma-
tion of a non-classical carbenium ion A2 as a direct precursor for product
formation is feasible.
Table 2. Scope of the rearrangement with respect to 1,1-diarylalkene.
Entry Substrate Ar t [h] Yield of 7 [%] ee of 7 [%]
1 6u 3-Cl-C6H4 6 68 68
2 6v 3-CF3-C6H4 7 41 46
3 6w 4-Cl-C6H4 6 79 77
4 6x 4-Br-C6H4 6 82 83
5 6y 4-Me-C6H4 1 90 86
6 6z 4-F-C6H4 7 73 87
7 6aa 2-Cl-C6H4 6 0 –
8 6bb 4-OMe-C6H4 2 0
[a] –
[a] Major product: 1,1-di(4-methoxyphenyl)pentan-2-one (72% yield).
Figure 2. Relaxed PES scan by sequentially changing the C1¢I bond length.
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iodine(I)!iodine(III) oxidation of chiral iodoarenes. Several oxi-
dants including oxone, selectfluor, sodium perborate, peracetic
acid and tert-butyl hydroperoxide were investigated, and best
results were obtained using meta-chloroperoxybenzoic acid
(mCPBA) and 2a (20 mol%, employed as the iodine(I)
compound leading to ketone 7a in 34% yield with 74% ee.
The stereoselective rearrangement protocol described above
was examined in a pharmaceutical context. Non-steroidal anti-
inflammatory drugs (NSAIDs) have found widespread clinical
application for their antipyretic, analgesic and anti-inflammato-
ry effects. Of these, cyclooxygenase-2 (COX-2)-selective inhibi-
tors have an established medicinal efficacy and have been the
focus of recent studies to determine their therapeutic effects
in tumour cell genesis and growth.[38] Racemic aryl ketone 8
(Scheme 6) has been identified as an analogue of the highly
selective COX-2 inhibitor lumiracoxib (9 ; Novartis).[39] From
commercially available materials, rac-8 can be efficiently syn-
thesized (89% yield from methyl 5,5-diphenylpent-4-enoate)
and (R)-8 can be synthesized with high enantioselectivity (89%
ee), as shown in Scheme 6. This methodology avoids the
potential toxicity from contamination with trace amounts of
transition metals, which otherwise would be required for its
synthesis. The conditions for the ester hydrolysis of 11 had to
be carefully selected. Hydrolysis under basic conditions or with
dilute hydrochloric acid led to unacceptable levels of
racemization, but employing p-toluenesulfonic acid avoided
racemization almost completely. In addition, access to (S)-8
should be possible using the reagent ent-2b derived from
commercially available (+)-methyl lactate.
Conclusion
We have developed a highly enantioselective oxidative
rearrangement of various 1,1-disubstituted alkenes employing
chiral hypervalent iodine reagents. This method provides an
attractive metal-free route to a-arylated ketones. The wider
scope of such oxidative rearrangements is currently under
investigation and will be reported in due course.
Experimental Section
Representative procedure for 7a : To the solution of alkene 6a
(0.18 mmol), reagent 2b (0.20 mmol) and methanol (0.54 mmol) in
CH2Cl2/TFE (10:1; 1.5 mL) at ¢78 8C, TsOH·H2O (0.18 mmol) was
added. The reaction mixture was stirred until completion (TLC),
then quenched with a 1:1 mixture of saturated aqueous NaHCO3
and saturated aqueous Na2S2O3 (0.5 mL). Then water (4 mL) was
added, and the aqueous phase was extracted with CH2Cl2 (3Õ
5 mL). The combined organic layers were filtered through a TELOS
Phase Separator and concentrated under vacuum to give the
crude product. Column chromatography (hexane/ethyl acetate
9:1!4:1) gave (R)-7a (87%, 94% ee) as a colourless oil.
Acknowledgements
This project was supported by EPSRC, grant no. EP/J00569X/1.
Support from EU (Marie Curie Fellowship to R.K. , SuSCIR, grant
no 621956) and the School of Chemistry, Cardiff University is
also gratefully acknowledged. We thank the EPSRC National
Mass Spectrometry Facility, Swansea, for mass spectrometric
analyses.
Keywords: alkenes · arylation · hypervalent iodine · oxidation ·
rearrangement
[1] a) Hypervalent Iodine Chemistry (Topics in Current Chemistry, Vol. 224 (Ed. :
T. Wirth), Springer, Berlin, 2003 ; b) V. V. Zhdankin, Hypervalent Iodine
Chemistry, Wiley, Chichester, 2014.
[2] a) M. Brown, U. Farid, T. Wirth, Synlett 2013, 24, 424–431; b) D.-Q. Dong,
S.-H. Hao, Z.-L. Wang, C. Chen, Org. Biomol. Chem. 2014, 12, 4278–
4289.
[3] C. A. Busacca, C. H. Senanayake, Transition Metal-Catalyzed Couplings in
Process Chemistry : Case Studies from the Pharmaceutical Industry (Eds. : J.
Magano, J. R. Dunetz), Wiley-VCH, Weinheim, 2003.
[4] a) M. Palucki, S. L. Buchwald, J. Am. Chem. Soc. 1997, 119, 11108–11109;
b) J. æhman, J. P. Wolfe, M. V. Troutman, M. Palucki, S. L. Buchwald, J.
Am. Chem. Soc. 1998, 120, 1918–1919; c) R. Martn, S. L. Buchwald,
Angew. Chem. Int. Ed. 2007, 46, 7236–7239; Angew. Chem. 2007, 119,
7374–7377.
[5] a) B. C. Hamann, J. F. Hartwig, J. Am. Chem. Soc. 1997, 119, 12382–
12383; b) X. Liao, Z. Weng, J. F. Hartwig, J. Am. Chem. Soc. 2008, 130,
195–200.
[6] T. Satoh, Y. Kawamura, M. Miura, M. Nomura, Angew. Chem. Int. Ed. Engl.
1997, 36, 1740–1742; Angew. Chem. 1997, 109, 1820–1822.
[7] a) X. Dai, N. A. Strotman, G. C. Fu, J. Am. Chem. Soc. 2008, 130, 3302–
3303; b) P. M. Lundin, J. Esquivias, G. C. Fu, Angew. Chem. Int. Ed. 2009,
48, 154–156; Angew. Chem. 2009, 121, 160–162; c) S. Lou, G. C. Fu, J.
Am. Chem. Soc. 2010, 132, 1264–1266.
[8] a) E. Marelli, M. Corpet, S. R. Davies, S. P. Nolan, Chem. Eur. J. 2014, 20,
17272–17276; b) S. M. Raders, J. M. Jones, J. G. Semmes, S. P. Kelley,
R. D. Rogers, K. H. Shaughnessy, Eur. J. Org. Chem. 2014, 7395–7404;
c) H. K. Potukuchi, A. P. Spork, T. J. Donohoe, Org. Biomol. Chem. 2015,
13, 4367–4373; d) L. Fan, S. Takizawa, Y. Takeuchi, K. Takenaka, H. Sasai,
Org. Biomol. Chem. 2015, 13, 4837–4840.
[9] a) R. Takise, K. Muto, J. Yamaguchi, K. Itami, Angew. Chem. Int. Ed. 2014,
53, 6791–6794; Angew. Chem. 2014, 126, 6909–6912; b) J. A. Fernn-
dez-Salas, E. Marelli, D. B. Cordes, A. M. Z. Slawin, S. P. Nolan, Chem. Eur.
J. 2015, 21, 3906–3909.
[10] C. C. C. Johansson, T. J. Colacot, Angew. Chem. Int. Ed. 2010, 49, 676–
707; Angew. Chem. 2010, 122, 686–718.
Scheme 6. Asymmetric synthesis of lumiracoxib analogue (R)-8.
Chem. Eur. J. 2016, 22, 4030 – 4035 www.chemeurj.org Ó 2016 The Authors. Published by Wiley-VCH Verlag GmbH&Co. KGaA, Weinheim4034
Full Paper
[11] a) C. He, S. Guo, L. Huang, A. Lei, J. Am. Chem. Soc. 2010, 132, 8273–
8275; b) A. E. Allen, D. W. C. MacMillan, J. Am. Chem. Soc. 2011, 133,
4260–4263; c) A. Bigot, A. E. Williamson, M. J. Gaunt, J. Am. Chem. Soc.
2011, 133, 13778–13781; d) J. S. Harvey, S. P. Simonovich, C. R. Jamison,
D. W. C. MacMillan, J. Am. Chem. Soc. 2011, 133, 13782–13785.
[12] C. H. Cheon, O. Kanno, F. D. Toste, J. Am. Chem. Soc. 2011, 133, 13248–
13251.
[13] a) B. Prìger, G. E. Hofmeister, C. B. Jacobsen, D. G. Alberg, M. Nielsen,
K. A. Jørgensen, Chem. Eur. J. 2010, 16, 3783–3790; b) X. Huang, N.
Maulide, J. Am. Chem. Soc. 2011, 133, 8510–8513; c) Z. Jia, E. Glvez,
R. M. Sebastin, R. Pleixats, Ý. Ýlvarez-Larena, E. Martin, A. Vallribera, A.
Shafir, Angew. Chem. Int. Ed. 2014, 53, 11298–11301; Angew. Chem.
2014, 126, 11480–11483; d) M. Pichette Drapeau, I. Fabre, L. Grimaud, I.
Ciofini, T. Ollevier, M. Taillefer, Angew. Chem. Int. Ed. 2015, 54, 10587–
10591; Angew. Chem. 2015, 127, 10733–10737; e) C. Dey, E. Lindstedt,
B. Olofsson, Org. Lett. 2015, 17, 4554–4557.
[14] a) M. Ochiai, Y. Kitagawa, N. Takayama, Y. Takaoka, M. Shiro, J. Am. Chem.
Soc. 1999, 121, 9233–9234; b) F. J. FaÇans, M. Alvarez-P¦rez, F. Rodr-
guez, Chem. Eur. J. 2005, 11, 5938–5944; c) P.-O. Norrby, T. B. Petersen,
M. Bielawski, B. Olofsson, Chem. Eur. J. 2010, 16, 8251–8254.
[15] a) G. F. Koser, L. Rebrovic, R. H. Wettach, J. Org. Chem. 1981, 46, 4324–
4326; b) L. Rebrovic, G. F. Koser, J. Org. Chem. 1984, 49, 2462–2472.
[16] a) G. Maertens, S. Canesi, Top. Curr. Chem. 2016, DOI: 10.1007/
128 2015 657; b) F. V. Singh, T. Wirth, Synthesis 2013, 45, 2499–2511;
c) K. C. Gu¦rard, A. Gu¦rinot, C. Bouchard-Aubin, M.-A. M¦nard, M.
Lepage, M. A. Beaulieu, S. Canesi, J. Org. Chem. 2012, 77, 2121–2133.
[17] a) F. A. Siqueira, E. E. Ishikawa, A. FogaÅa, A. T. Faccio, V. M. T. Carneiro,
R. R. S. Soares, A. Utaka, I. R. M. T¦b¦ka, M. Bielawski, B. Olofsson, L. F.
Silva, J. Braz. Chem. Soc. 2011, 22, 1795–1807; b) A. Ahmad, P. Scarassa-
ti, N. Jalalian, B. Olofsson, L. F. Silva, Tetrahedron Lett. 2013, 54, 5818–
5820.
[18] a) L. Liu, L. Du, D. Zhang-Negrerie, Y. Du, K. Zhao, Org. Lett. 2014, 16,
5772–5775; b) L. Liu, D. Zhang-Negrerie, Y. Du, K. Zhao, Synthesis 2015,
47, 2924–2930.
[19] a) A. C. Boye, D. Meyer, C. K. Ingison, A. N. French, T. Wirth, Org. Lett.
2003, 5, 2157–2159; b) F. V. Singh, J. Rehbein, T. Wirth, ChemistryOpen
2012, 1, 245–250.
[20] M. W. Justik, G. F. Koser, Tetrahedron Lett. 2004, 45, 6159–6163.
[21] For leading reviews, see: a) R. Kumar, T. Wirth, Top. Curr. Chem. 2016,
DOI: 10.1007/128 2015 639; b) F. Berthiol, Synthesis 2015, 47, 587–603;
c) A. Parra, S. Reboredo, Chem. Eur. J. 2013, 19, 17244–17260; d) H.
Liang, M. Ciufolini, Angew. Chem. Int. Ed. 2011, 50, 11849–11851;
Angew. Chem. 2011, 123, 12051–12053.
[22] M. Uyanik, T. Yasui, K. Ishihara, Angew. Chem. Int. Ed. 2010, 49, 2175–
2177; Angew. Chem. 2010, 122, 2221–2223.
[23] U. Farid, F. Malmedy, R. Claveau, L. Albers, T. Wirth, Angew. Chem. Int. Ed.
2013, 52, 7018–7022; Angew. Chem. 2013, 125, 7156–7160.
[24] a) M. Zhu, Y. Zhao, Chin. Chem. Lett. 2015, 26, 248–250; b) V. C. Purohit,
S. P. Allwein, R. P. Bakale, Org. Lett. 2013, 15, 1650–1653.
[25] M. Fujita, Y. Yoshida, K. Miyata, A. Wakisaka, T. Sugimura, Angew. Chem.
Int. Ed. 2010, 49, 7068–7071; Angew. Chem. 2010, 122, 7222–7225.
[26] P. Mizar, A. Laverny, M. El-Sherbini, U. Farid, M. Brown, F. Malmedy, T.
Wirth, Chem. Eur. J. 2014, 20, 9910–9913.
[27] M. Brown, M. Delorme, F. Malmedy, J. Malmgren, B. Olofsson, T. Wirth,
Synlett 2015, 26, 1573–1577.
[28] Endo- and exo-cyclic aryl alkenes have been shown to give rearrange-
ment products on treatment with hydroxy(tosyloxy)iodobenzene 1 (see
Ref. [19]). With reagents 2b and 3, poor chemoselectivities were ob-
served on reaction with model substrates 1-phenyl-1-cyclohexene and
9-butylidenefluorene.
[29] M. Fujita, S. Okuno, H. J. Lee, T. Sugimura, T. Okuyama, Tetrahedron Lett.
2007, 48, 8691–8694.
[30] U. Scheffler, R. Mahrwald, Helv. Chim. Acta 2012, 95, 1970–1975.
[31] S. Q. Jin, R. Z. Liu, Int. J. Quantum Chem. 1984, 25, 699–705.
[32] Gaussian 09, Revision D.01, M. J. Frisch, G. W. Trucks, H. B. Schlegel, G. E.
Scuseria, M. A. Robb, J. R. Cheeseman, G. Scalmani, V. Barone, B. Men-
nucci, G. A. Petersson, H. Nakatsuji, M. Caricato, X. Li, H. P. Hratchian,
A. F. Izmaylov, J. Bloino, G. Zheng, J. L. Sonnenberg, M. Hada, M. Ehara,
K. Toyota, R. Fukuda, J. Hasegawa, M. Ishida, T. Nakajima, Y. Honda, O.
Kitao, H. Nakai, T. Vreven, J. A. Montgomery, Jr. , J. E. Peralta, F. Ogliaro,
M. Bearpark, J. J. Heyd, E. Brothers, K. N. Kudin, V. N. Staroverov, R. Ko-
bayashi, J. Normand, K. Raghavachari, A. Rendell, J. C. Burant, S. S. Iyen-
gar, J. Tomasi, M. Cossi, N. Rega, J. M. Millam, M. Klene, J. E. Knox, J. B.
Cross, V. Bakken, C. Adamo, J. Jaramillo, R. Gomperts, R. E. Stratmann,
O. Yazyev, A. J. Austin, R. Cammi, C. Pomelli, J. W. Ochterski, R. L. Martin,
K. Morokuma, V. G. Zakrzewski, G. A. Voth, P. Salvador, J. J. Dannenberg,
S. Dapprich, A. D. Daniels, ©. Farkas, J. B. Foresman, J. V. Ortiz, J. Cio-
slowski, D. J. Fox, Gaussian, Inc. Wallingford CT, 2009. M06–2X/D95 V
for H and D95 V [d] for all other atoms except iodine (LANL2DZ(d,p)
with ECPs LANL2DZ).
[33] Conformational searches for A1 were conducted in respect to the ori-
entation of the phenyl ring attached to the iodide. p-stacking in A1-p
cannot override steric repulsion and leads to a small energy difference
in favour of A1.
[34] Y. Zhao, D. G. Truhlar, Theor. Chem. Acc. 2008, 120, 215–241. M06–2X
has been chosen to model the various iodonium and carbenium ions
because of its reasonable performance in standard non-covalent inter-
action tests. See: G. A. DiLabio, A. Otero-de-la-Roza in Review in Compu-
tational Chemistry, Vol. 29 (Eds. : A. L. Parrill, K. B. Lipkowitz), Wiley, 2016.
[35] a) C. T. Lee, W. T. Yang, R. G. Parr, Phys. Rev. B 1988, 37, 785–789; b) A. D.
Becke, J. Chem. Phys. 1993, 98, 5648–5652; c) P. J. Stephens, F. J. Devlin,
C. F. Chabalowski, M. J. Frisch, J. Phys. Chem. 1994, 98, 11623–11627;
d) A. D. Becke, Phys. Rev. A 1988, 38, 3098–3100; e) W. J. Hehre, R.
Ditchfie, J. A. Pople, J. Chem. Phys. 1972, 56, 2257–2261; f) P. C. Harihar-
an, J. A. Pople, Theor. Chim. Acta 1973, 28, 213–222.
[36] Bonding asymmetry was determined by comparing the calculated C1¢I
and C2¢I bond lengths with the C1’¢I, C2’¢I bond length of the parent
iodonium ion A1 for each level of theory.
[37] a) M. Uyanik, T. Yasui, K. Ishihara, Angew. Chem. Int. Ed. 2013, 52, 9215–
9218; Angew. Chem. 2013, 125, 9385–9388; b) T. Dohi, N. Takenaga, T.
Nakae, Y. Toyoda, M. Yamasaki, M. Shiro, H. Fujioka, A. Maruyama, Y.
Kita, J. Am. Chem. Soc. 2013, 135, 4558–4566; c) P. Mizar, A. Burrelli, E.
Gìnther, M. Sçftje, U. Farooq, T. Wirth, Chem. Eur. J. 2014, 20, 13113–
13116.
[38] a) B. Singh, A. Lucci, J. Surg. Res. 2002, 108, 173–179; b) L. W. C. Chow,
W. T. Y. Loo, M. Toi, Biomed. Pharmacother. 2005, 59, S281–S284; c) Y.
Pan, S. Xu, X. Jia, H. Xu, Y. Zhang, Exp. Oncol. 2007, 29, 23–29.
[39] R. Bartzatt, Antiinflamm. Antiallergy Agents Med. Chem. 2014, 13, 17–28.
Received: December 2, 2015
Published online on January 21, 2016
Chem. Eur. J. 2016, 22, 4030 – 4035 www.chemeurj.org Ó 2016 The Authors. Published by Wiley-VCH Verlag GmbH&Co. KGaA, Weinheim4035
Full Paper
